fludeoxyglucose (18F) 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4455 105851-17-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • fludeoxyglucose F-18
  • fludeoxyglucose F 18
  • fludeoxyglucose (18F)
  • Molecular weight: 181.15
  • Formula: C6H11FO5
  • CLOGP: -2.01
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 4
  • TPSA: 90.15
  • ALOGS: 0.15
  • ROTB: 1
  • Status: OFP
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Aug. 19, 1994 FDA DOWNSTATE CLINCL

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Cytokine release syndrome 72.45 51.19 17 127 22860 34933927

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Cytokine release syndrome 54.87 51.09 13 150 35985 79708240

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC V09IX04 VARIOUS
DIAGNOSTIC RADIOPHARMACEUTICALS
TUMOUR DETECTION
Other diagnostic radiopharmaceuticals for tumour detection
FDA MoA N0000000205 Radiopharmaceutical Activity
FDA EPC N0000177914 Radioactive Diagnostic Agent

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 11.1 acidic
pKa2 12.31 acidic
pKa3 14.0 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4024383 VUID
N0000168559 NUI
63503-12-8 SECONDARY_CAS_RN
4024383 VANDF
CHEBI:31617 CHEBI
CHEMBL1092067 ChEMBL_ID
CHEMBL497613 ChEMBL_ID
DB09502 DRUGBANK_ID
450503 PUBCHEM_CID
1362737 RXNORM
15670 MMSL
194386 MMSL
d04705 MMSL
003334 NDDF
C0046056 UMLSCUI
6446 INN_ID
0Z5B2CJX4D UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG LABEL 1 13267-123 INJECTION 300 mCi INTRAVENOUS NDA 16 sections
FludeoxyglucoseF18 HUMAN PRESCRIPTION DRUG LABEL 1 13267-234 INJECTION 400 mCi INTRAVENOUS NDA 16 sections
Fludeoxyglucose F-18 HUMAN PRESCRIPTION DRUG LABEL 1 16129-001 INJECTION 300 mCi INTRAVENOUS ANDA 25 sections
Fludeoxyglucose F-18 HUMAN PRESCRIPTION DRUG LABEL 1 16129-001 INJECTION 300 mCi INTRAVENOUS ANDA 25 sections
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG LABEL 1 24275-0185 INJECTION 300 mCi INTRAVENOUS ANDA 16 sections
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG LABEL 1 24275-0185 INJECTION 300 mCi INTRAVENOUS ANDA 16 sections
FLUDEOXYGLUCOSE F 18 HUMAN PRESCRIPTION DRUG LABEL 1 24417-001 INJECTION 300 mCi INTRAVENOUS ANDA 17 sections
FLUDEOXYGLUCOSE F 18 HUMAN PRESCRIPTION DRUG LABEL 1 24417-001 INJECTION 300 mCi INTRAVENOUS ANDA 17 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 24445-334 INJECTION 300 mCi INTRAVENOUS ANDA 26 sections
FLUDEOXYGLUCOSE F-18 HUMAN PRESCRIPTION DRUG LABEL 1 24450-647 INJECTION 300 mCi INTRAVENOUS ANDA 25 sections
Fludeoxyglucose F-18 HUMAN PRESCRIPTION DRUG LABEL 1 24468-001 INJECTION 500 mCi INTRAVENOUS ANDA 22 sections
FludeoxyglucoseF 18 HUMAN PRESCRIPTION DRUG LABEL 1 24562-001 INJECTION, SOLUTION 300 mCi INTRAVENOUS ANDA 24 sections
FludeoxyglucoseF 18 HUMAN PRESCRIPTION DRUG LABEL 1 24562-001 INJECTION, SOLUTION 300 mCi INTRAVENOUS ANDA 24 sections
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG LABEL 1 24562-003 INJECTION, SOLUTION 300 mCi INTRAVENOUS ANDA 24 sections
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG LABEL 1 24562-003 INJECTION, SOLUTION 300 mCi INTRAVENOUS ANDA 24 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 29998-001 INJECTION 40 mCi INTRAVENOUS ANDA 28 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 29998-001 INJECTION 40 mCi INTRAVENOUS ANDA 28 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 40028-511 INJECTION, SOLUTION 200 mCi INTRAVENOUS ANDA 23 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 40028-511 INJECTION, SOLUTION 200 mCi INTRAVENOUS ANDA 23 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 40028-511 INJECTION, SOLUTION 200 mCi INTRAVENOUS ANDA 23 sections
Fludeoxyglucose F-18 HUMAN PRESCRIPTION DRUG LABEL 1 40098-101 INJECTION, SOLUTION 200 mCi INTRAVENOUS ANDA 24 sections
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG LABEL 1 44338-001 INJECTION, SOLUTION 500 mCi INTRAVENOUS ANDA 26 sections
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG LABEL 1 49609-001 INJECTION 500 mCi INTRAVENOUS ANDA 17 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 49609-101 INJECTION 300 mCi INTRAVENOUS ANDA 25 sections
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG LABEL 1 51760-001 INJECTION 300 mCi INTRAVENOUS ANDA 16 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 52670-551 INJECTION 240 mCi INTRAVENOUS ANDA 24 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 52670-551 INJECTION 240 mCi INTRAVENOUS ANDA 24 sections
Fludeoxyglucose F-18 HUMAN PRESCRIPTION DRUG LABEL 1 52768-001 INJECTION, SOLUTION 500 mCi INTRAVENOUS ANDA 27 sections
Fludeoxyglucose F-18 HUMAN PRESCRIPTION DRUG LABEL 1 52768-001 INJECTION, SOLUTION 500 mCi INTRAVENOUS ANDA 27 sections
Fludeoxyglucose F 18 HUMAN PRESCRIPTION DRUG LABEL 1 60055-334 INJECTION, SOLUTION 300 mCi INTRAVENOUS ANDA 24 sections